article thumbnail

Abridge clinches $150M to build out generative AI for medical documentation

Fierce Healthcare

. | Along with the funding round, Abridge also announced an enterprise agreement with Connecticut-based Yale New Haven Health System to give thousands of clinicians access to its AI-powered clinical documentation technology.

article thumbnail

STAT+: Juul spent big to court Black leaders to promote its e-cigarettes, new documents show

STAT

Documents released this week shed new light on an aggressive strategy from vape maker Juul to court Black leaders, including the Rev. Al Sharpton, to publicly support its e-cigarettes. It’s not clear how much the company ultimately spent on the partnerships. Continue to STAT+ to read the full story…

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Industry Voices—Not all automation is created equally for clinical documentation improvement

Fierce Healthcare

Industry Voices—Not all automation is created equally for clinical documentation improvement. Wed, 09/15/2021 - 15:26.

article thumbnail

STAT+: HCA to expand the use of AI tool to automate clinical documentation in ER

STAT

HCA Healthcare, the largest for-profit hospital chain in the United States, is planning to expand the use of an artificial intelligence tool to document doctor-patient interactions in its emergency rooms.

article thumbnail

STAT+: Microsoft to embed AI tool for clinical documentation in Epic’s health records software

STAT

Microsoft on Thursday said it will launch its artificial intelligence tool for automating clinical documentation within health records software made by Epic, a move to embed the technology in health systems nationwide.

article thumbnail

Granules India scolded over truckloads of torn manufacturing documents after recent FDA inspection

Fierce Pharma

From truckloads of torn documents to avian incursions in the production plant, Granules India’s recent manufacturing reprimand from the FDA is alarming no matter which way you look at it. Earlier this month, Granules was slapped with a Form 483 following an inspection of its Telangana facility in India that ran from Aug. 26 to Sept.

article thumbnail

STAT+: Brain biopsies on ‘vulnerable’ patients at Mount Sinai set off alarm bells at FDA, documents show

STAT

In study documents, Mount Sinai doctors said the biopsies result in “the same amount of tissue loss” and “in effect, the same level of risk” for patients as standard DBS, because they are removing tissue that would otherwise be cauterized.